Judy E. Garber, MD, MPH
Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts
An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer. She has led studies of epidemiology, cancer surveillance, cancer genetics service delivery, and chemoprevention in hereditary cancers.
Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer, the most common form of cancer in women with germline BRCA1 mutations. She has also studied pediatric cancers and sarcomas in Li-Fraumeni and hereditary gastrointestinal and stromal tumors.
2019 ASCO American Cancer Society Award and Lecture2018 Giants of Cancer Care, OncLive®, Cranbury, New Jersey2017 AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research2012 Elected Member, American Association of Physicians2011-2012 President, AACR2011 Professor of Medicine, Harvard Medical School2010 Director, Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute2010 Axia Award, Hellenic Women’s Club2009 Claire W. and Richard P. Morse Research Award, Dana Farber Cancer Institute2008 Statesman Award, American Society for Clinical Oncology2007 Tisch Family Outstanding Achievement Award, Dana Farber Cancer Institute2007-2010 Board of Directors, AACR2001 Elected to American Society for Clinical Investigation1997-2000 Scholar in Clinical Research, The Dyson Foundation1981 MD, MPH, Yale University School of Medicine